Open Access

Convergent synthesis of 13N-labelled Peptidic structures using aqueous [13N]NH3

EJNMMI Radiopharmacy and Chemistry20172:16

Received: 21 September 2017

Accepted: 1 December 2017

Published: 19 December 2017



Nitrogen-13 has a 10-min half-life which places time constraints on the complexity of viable synthetic methods for its incorporation into PET imaging agents. In exploring ways to overcome this limitation, we have used the Ugi reaction to develop a rapid one-pot method for radiolabelling peptidic molecules using [13N]NH3 as a synthetic precursor.


Carrier-added [13N]NH3 (50 μL) was added to a solution of carboxylic acid, aldehyde, and isocyanide in 2,2,2-TFE (200 μL). The mixture was heated in a microwave synthesiser at 120 °C for 10 min. Reactions were analysed by radio-HPLC and radio-LCMS. Isolation of the target 13N–labelled peptidic Ugi compound was achieved via semi-preparative radio-HPLC as demonstrated for Ugi1.


Radio-HPLC analysis of each reaction confirmed the formation of radioactive products co-eluting with their respective reference standards with radiochemical yields of the crude products ranging from 11% to 23%. Two cyclic γ-lactam structures were also achieved via intra-molecular reactions. Additional radioactive by-products observed in the radio-chromatogram were identified as 13N–labelled di-imines formed from the reaction of [13N]NH3 with two isocyanide molecules. The desired 13N–labelled Ugi product was isolated using semi-preparative HPLC.


We have developed a one-pot method that opens up new routes to radiolabel complex, peptidic molecules with 13N using aqueous [13N]NH3 as a synthetic precursor.


PET chemistryNitrogen-13[13N]ammoniaMulticomponent reactionPeptideUgi


Nitrogen-13 (t1/2 = 9.97 min; 100% β+ decay) is used clinically in the field of positron emission tomography (PET). Compared to other cyclotron-produced positron emitters such as 18F and 11C, 13N has been largely overlooked as a viable option for radiolabelling as its short half-life poses challenges to the development of synthetic methods. Despite its limited use, 13N offers many favourable attributes that may be complementary to conventional 11C and 18F labelling: the ubiquity of nitrogen in endogenous molecules and pharmaceuticals allows direct labelling of molecules of interest without interfering with their biological activity, enabling study of authentic biogenic molecules, and the short half-life offers the ability to repeat PET scans on the same individual within a short time and without excessive radiation dose to the patient. Cyclotron-produced 13N is most commonly generated by the proton bombardment of [16O]H2O via the nuclear reaction 16O(p,α)13N to produce [13N]NH3 (Wieland et al., 1991), which is the only routinely-used 13N radiopharmaceutical (for myocardial perfusion imaging) but can also be a potentially useful radiolabelling precursor (Kumata et al., 2010; Kumata et al., 2012; Gomez-Vallejo et al., 2014).

Multi-component reactions are powerful tools in the efficient and rapid generation of diverse libraries of compounds, and are particularly useful for high-throughput screening. The four-component Ugi reaction combines a carboxylic acid, an amine (sometimes ammonia), an aldehyde or ketone, and an isocyanide to create α-aminoacyl amide derivatives - peptidomimetic structures with proven pharmaceutical application (Domling & Ugi, 2000). Notably, the one-pot synthesis of the local anaesthetic Xylocain and the subsequent development and marketing of at least 12 other anaesthetics is based on this scaffold (Hulme & Gore, 2003). The Ugi reaction is therefore an attractive method for the rapid radiolabelling of peptides with short-lived PET radionuclides, useful in diagnosis, drug discovery and as a research tool in understanding molecular mechanisms in vivo. Here we report the radiolabelling of α-aminoacyl amide derivatives with 13N, via the four-component coupling (4-CC) Ugi synthesis, using aqueous [13N]NH3 as a precursor.



Benzaldehyde (≥99%), levulinic acid (98%), p-toluic acid (98%), tert-butyl isocyanide (98%) and trifluoroacetic acid (99%) were purchased from Sigma-Aldrich. Benzyl isocyanide (98%) and 2,2,2-trifluoroethanol (99.8%) were purchased from Acros Organics. 1,1,3,3-tetramethylbutyl isocyanide and ammonia solution (28–30%) were purchased from Merck KGaA. Acetic acid (~100%) was purchased from AnalaR. Methanol (HPLC grade) was purchased from Fisher.

Reactions were carried out using a CEM Discover microwave synthesis unit.

1H–NMR and 13C–NMR spectra were obtained using a Bruker DRX 400 MHz spectrometer. Mass spectrometry was performed on an Agilent Technologies 6520 Accurate-Mass Q-TOF LC/MS connected to an Agilent Technologies1200 HPLC system with UV detector and autosampler.

Radio-HPLC analysis was performed on an Agilent Technologies 1200 Series with UV detector (254 nm) and Lablogic β + radio-detector using an Agilent Eclipse XDB-C18 column (5 μm, 4.6 × 150 mm). The following mobile phase conditions were used: solvent A: H2O + 0.1% TFA; solvent B: MeOH +0.1% TFA; time:%B 0:5, 1:5, 10:95, 18:5, 23:5. Flow rate was 1 mL/min.

Reference standard synthesis

For reference standard compounds 1–5, benzaldehyde (2 mmol), the respective carboxylic acid (p-toluic acid (2, 4) or acetic acid (1, 3, 5), 2 mmol), the respective isocyanide (tert-butyl isocyanide (4, 5), benzyl isocyanide (3) or 1,1,3,3-tetramethylbutyl isocyanide (1, 2), 2 mmol) and ammonia (excess, ~ 3 mmol) were combined in 2,2,2-trifluoroethanol (TFE, 2 mL) in a microwave tube. For reference standard compounds 6–7, levulinic acid (2 mmol), the respective isocyanide (benzyl isocyanide (6) or tert-butyl isocyanide (7), 2 mmol) and ammonia (excess, ~ 3 mmol) were combined in TFE (2 mL) in a microwave tube. The mixture was heated at 100 °C for 30 min in a microwave synthesis unit. The reaction mixture was cooled to room temperature and the solvent was removed under vacuum. The crude product was filtered and washed with ice-cold methanol. The final product was isolated using semi-preparative HPLC and lyophilised.


[13N]NH3 production

Aqueous [13N]NH3 was produced on a CTI RDS 112 biomedical cyclotron via the 16O(p,α)13N nuclear reaction. The target contained 8 mL H2O with 5 mM ethanol. Concentration of [13N]NH3 into a 1 mL volume was carried out using a weak cation exchange Sep-Pak (Accell Plus CM Light, Waters.) and eluted with saline (0.9%, 1 mL).

Radiolabelling of 1–7

For radiolabelling of 1–5, benzaldehyde (48.5 μmol), the respective carboxylic acid (p-toluic acid (2, 4) or acetic acid (1, 3, 5), 48.5 μmol), the respective isocyanide (tert-butyl isocyanide (4, 5), benzyl isocyanide (3) or 1,1,3,3-tetramethylbutyl isocyanide (1, 2), 48.5 μmol), ammonium hydroxide solution (28–30%, 10 μL, 148 μmol) and [13N]NH3 (50 μL) were combined in 2,2,2-trifluoroethanol (200 μL) in a microwave tube. For radiolabelling of 6–7, levulinic acid (48.5 μmol), the respective isocyanide (benzyl isocyanide (6) or tert-butyl isocyanide (7), 48.5 μmol), ammonium hydroxide solution (28–30%, 10 μL, 148 μmol) and [13N]NH3 (50 μL) were combined in 2,2,2-trifluoroethanol (200 μL) in a microwave tube. The mixture was heated at 120 °C for 10 min in a microwave synthesis unit with stirring. The reaction mixture was cooled to room temperature and analysed via radio-HPLC. The desired 13N–labelled Ugi product was isolated using semi-preparative HPLC.


Reference standard synthesis

Based on methods developed by Thompson et al. (Thompson & Chen, 2009), reference standards 1–7 were successfully synthesised and isolated. LC/MS analysis of the crude product mixtures confirmed the presence of the desired 4-CC products. Full characterisation of the final isolated products can be found in the Additional file 1.


Radiosynthesis of 1–5 was achieved via the Ugi reaction by combining benzaldehyde, the respective carboxylic acid and isocyanide, and carrier-added aqueous [13N]NH3 (Fig. 1). Radiosynthesis of cyclic γ-lactams 6–7 was achieved using an intra-molecular Ugi reaction by combining the ketone and carboxylic acid in a single molecule – levulinic acid - with the respective isocyanide, and carrier-added [13N]NH3 (Fig. 1). All reaction mixtures were heated using a microwave synthesis unit. Synthesis of 1 was selected as the model reaction for optimisation (Table 1). Initially, experiments were performed in a range of solvents and heated at 100 °C for 15 min. The optimum solvent was found to be TFE, affording radiochemical yields (RCY, based on radio-HPLC analysis of the crude product) of 13%, performing better than MeCN (9%), while DMF afforded no yield (Table 1, entries 1–3). Reaction time and temperature were varied, with little effect on RCY (Table 1, entries 4–8). A reaction time of 10 min at a temperature of 120 °C was found to give optimal RCY (Table 1, entry 7). However, halving the reaction time only marginally reduced the RCY from 14% to 12%. Thus, taking into account radioactive decay, a shorter reaction time of 5 min would ultimately give higher activity yield (Table 1, entry 8), and would be more practically useful in a clinical scenario. The RCY was found to have the greatest dependency on the amount of carrier ammonia added. Increasing the amount of carrier ammonia from 5 μL (74 μmol) to 10 μL (148 μmol) led to an increase in RCY from 14% to 23%, respectively (Table 1, entries 7 and 9). A further increase to 20 μL (296 μmol) resulted in a decrease in RCY to 16% (Table 1, entry 10). Under no-carrier-added conditions, the desired labelled product was not observed. Increasing the volume of the aqueous [13N]NH3 in the reaction from 50 μL to 100 μL resulted in a significant decrease in RCY.
Fig. 1

Synthesis of 13N–labelled α-aminoacyl amide derivatives (1–5) and γ-lactams (6–7)

Table 1

Reaction optimisation

The established optimum conditions of 1 were applied to the radiosynthesis of a small library of compounds. 13N–labelling of target structures 1–7 was confirmed by the co-elution of the non-radioactive standards and radio-LC/MS analysis. The radiochemical yield of these compounds ranged from 11 to 23% (Table 2). The molar activity of [13N]NH3 used in these experiments was 2.64 ± 0.12 GBq/μmol. In addition to the target Ugi compound and un-reacted [13N]NH3, another unknown radiolabelled species was observed (Fig. 2). However, semi-preparative HPLC could be used to isolate the desired 13N–labelled Ugi product. To demonstrate this, isolation of 1 was carried out, achieving 96% radiochemical purity (Fig. 3) and an activity yield between 4 and 6% (based on 24 min preparation time).
Table 2

Radiolabelling of a small library of 13N–labelled α-aminoacyl amide derivatives and γ-lactams

Fig. 2

HPLC chromatogram of the crude radiolabelled product (Table 1, entry 9). a Radioactivity (counts per second); target compound 1 at Rt 11.58 min; unreacted [13N]NH3 at Rt 1.82 min; unknown by-product at Rt 8.55 min. b UV absorption (254 nm) of reaction 1

Fig. 3

HPLC chromatogram of the isolated radiolabelled product 1. a Radioactivity (counts per second); b UV absorption (254 nm)

To identify the radioactive by-products, analogous reactions using stable isotope labelling with 14N and 15N were carried out, followed by LC/MS analysis to establish a molecular weight associated with the by-products. In each case, the molecular weight corresponded to the combination of one [14/15N]NH3 molecule and two isocyanide molecules, suggesting the formation of labelled di-imine structures (Fig. 4).
Fig. 4

Structures of radiolabelled by-products formed from reaction of [13N]NH3 with two molecules of a 1,1,3,3-tetramethylbutyl isocyanide; b tertbutyl isocyanide and c benzyl isocyanide


Ammonia is rarely used as the amine component in the Ugi reaction, as it reportedly leads to low yields and extensive by-product formation. A common by-product is the six-component coupling (6-CC) product formed through participation of the solvent (usually methanol) (Ackermann et al., 2012; Kazmaier & Hebach, 2003). Thompson et al. synthesised a library of structures via the Ugi reaction using ammonia, and replacing methanol with the less nucleophilic solvent TFE suppressed formation of the 6-CC product in favour of the desired 4-CC product (Thompson & Chen, 2009). Therefore, in the present study TFE was used for all reactions. Using this strategy, reference standards 1–7 were successfully synthesised. LC/MS analysis of the crude product mixtures confirmed the presence of the desired 4-CC product, with no evidence for a 6-CC product.

The radiolabelling of structures 1–7 via the Ugi reaction using aqueous carrier-added [13N]NH3 as a precursor was successful, with RCYs ranging from 11 to 23%. Under the tested conditions, the reaction did not proceed in the absence of carrier-added ammonia and the RCY varied significantly depending on the amount of carrier ammonia added: reducing the amount of ammonia from 10 μL (2.9 equivalents) to near stoichiometric amounts (5 μL, 1.4 equivalents) reduced the RCY; increasing to 20 μL (6 equivalents), also reduced the RCY. Therefore, 10 μL was selected for all subsequent reactions. We note that under these specific high temperature, closed vessel microwave conditions, the amount of ammonia in the solution versus the gas phase (and thus unavailable for reaction) has not been quantified. The necessary addition of carrier ammonia to this reaction mixture will inherently result in a tracer with low molar activity, potentially preventing the targeting of low-abundance receptors. The detrimental effect on the RCY upon increasing the volume of aqueous [13N]NH3 suggests this reaction could be affected by the presence of water and may benefit from anhydrous conditions.

The use of microwave technology is often beneficial when rapid chemistry is required, particularly when using such short-lived isotopes as nitrogen-13. A limited number of experiments using conventional heating methods showed the target product could be obtained, but in lower RCY than that obtained using microwave heating. This indicates that the use of microwave technology is indeed effective in this case (see Additional file 1).

Despite the presence of un-reacted [13N]NH3 and radioactive by-products in the crude reaction mixture, the desired 13N–labelled Ugi product could be easily isolated using semi-preparative HPLC, as demonstrated for reaction 1. The UV chromatogram of the final isolated product showed two major products co-eluting with the radioactive product. These are likely to be the non-radioactive α-aminoacyl amide Ugi product, and a structurally similar α-acyloxy amide, the product of the three-component coupling Passerini reaction between the isocyanide, carboxylic acid and aldehyde (see Additional file 1). This is consistent with our observations of the presence of the 3-component coupling Passerini product in the LC/MS analysis of the crude reaction mixture during synthesis of the non-radioactive reference standards, and in the analogous 15N reactions. The radioactive by-products observed in the radio-chromatograms of all reactions 1–7 were identified as 13N–labelled di-imines in which one [13N]NH3 molecule reacts with the electrophilic carbon of two isocyanide molecules to form the 13N–labelled di-imine (Fig. 4). Identification of these by-products further contributes to expanding the breadth of known radiochemistry available for radiosynthesis with [13N]NH3. Derivatisation of R1 and R2 substituents via the isocyanide and carboxylic acid moieties bearing targeting groups such as peptides, sugars or other functional groups, could enable rapid access to libraries of functionalised 13N–labelled compounds. Furthermore, it may be possible to label molecules of specific biological interest using this method, such as 1,4-benzodiazepine-2,5-diones which have shown promise as anticonvulsant agents, opiate receptor antagonists and as inhibitors of histone deacetylases which are linked to the pathogenesis of several cancers (Hulme et al., 1998; Loudni et al., 2007).


The novel methodology presented here demonstrates an efficient strategy for quickly obtaining libraries of diverse 13N–labelled peptidomimetics. The Ugi reaction has been successfully adapted to radiolabel a library of α-aminoacyl amide derivatives and γ-lactams with 13N from cyclotron-produced aqueous [13N]NH3 precursor in a one-pot method. This is also the first report of radiosynthesis with 13N using microwave heating technology. This work demonstrates that despite its short half-life, complex molecules can be rapidly labelled with 13N and as such, 13N should be regarded as a viable option for labelling peptides in the future.



Four-component coupling


Six-component coupling


Dimethyl formamide


Positron emission tomography


Radiochemical yield


Trifluoroacetic acid





Not applicable

Availability of data and materials

The data set supporting the conclusion of this article is included within the article and its additional file.


This research was supported by the PET Centre at St Thomas’ Hospital and the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy’s & St Thomas’ NHS Foundation Trust in partnership with King’s College London and King’s College Hospital NHS Foundation Trust. This research was also supported by The Centre of Excellence in Medical Engineering funded by the Wellcome Trust and EPSRC under grant number WT 088641/Z/09/Z, and the KCL and UCL Comprehensive Cancer Imaging Centre funded by CRUK and EPSRC in association with the MRC and Department of Health (England). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the DoH.

Authors’ contributions

ADG and JEB jointly conceived the study. JEB designed and coordinated the study. JEB and SFC conducted the chemical synthesis. JEB and SFC conducted the radiochemistry development and optimisation. The manuscript was drafted by JEB and ADG. All authors read and approved the final manuscript.

Authors’ information

Not applicable

Ethics approval and consent to participate

Not applicable

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors’ Affiliations

King’s College London, School of Biomedical Engineering and Imaging Sciences, London, UK


  1. Ackermann S, Lerchen HG, Habich D, Ullrich A, Kazmaier U. Synthetic studies towards bottromycin. Beilstein J Org Chem. 2012;8:1652–6.View ArticlePubMedPubMed CentralGoogle Scholar
  2. Domling A, Ugi II. Multicomponent reactions with isocyanides. Angew Chem Int Ed Engl. 2000;39(18):3168–210.View ArticlePubMedGoogle Scholar
  3. Gomez-Vallejo V, Gaja V, Gona KB, Llop J. Nitrogen-13: historical review and future perspectives. J Labelled Comp Radiopharm. 2014;57(4):244–54.View ArticlePubMedGoogle Scholar
  4. Hulme C, Gore V. “Multi-component reactions : emerging chemistry in drug discovery” ‘From xylocain to crixivan’. Curr Med Chem. 2003;10(1):51–80.View ArticlePubMedGoogle Scholar
  5. Hulme C, Peng J, Tang SY, Burns CJ, Morize I, Labaudiniere R. Improved procedure for the solution phase preparation of 1,4-benzodiazepine-2,5-dione libraries via Armstrong's convertible isonitrile and the Ugi reaction. J Org Chem. 1998;63(22):8021–3.View ArticleGoogle Scholar
  6. Kazmaier U, Hebach C. Peptide syntheses via Ugi reactions with ammonia. Synlett. 2003;11:1591–4.View ArticleGoogle Scholar
  7. Kumata K, Ogawa M, Takei M, Fujinaga M, Yoshida Y, Nengaki N, et al. Radiosynthesis of [13N]dantrolene, a positron emission tomography probe for breast cancer resistant protein, using no-carrier-added [13N]ammonia. Bioorg Med Chem. 2012;20(1):305–10.View ArticlePubMedGoogle Scholar
  8. Kumata K, Takei M, Ogawa M, Yui J, Hatori A, Suzuki K, et al. Radiosynthesis of 13N-labeled thalidomide using no-carrier-added [13N]NH3. J Labelled Comp Radiopharm. 2010;53(2):5.Google Scholar
  9. Loudni L, Roche J, Potiron V, Clarhaut J, Bachmann C, Gesson JP, et al. Design, synthesis and biological evaluation of 1,4-benzodiazepine-2,5-dione-based HDAC inhibitors. Bioorg Med Chem Lett. 2007;17(17):4819–23.View ArticlePubMedGoogle Scholar
  10. Thompson MJ, Chen B. Ugi reactions with ammonia offer rapid access to a wide range of 5-aminothiazole and oxazole derivatives. J Org Chem. 2009;74(18):7084–93.View ArticlePubMedGoogle Scholar
  11. Wieland B, Bida G, Padgett H, Hendry G, Zippi E, Kabalka G, et al. In-target production of [13N]ammonia via proton irradiation of dilute aqueous ethanol and acetic acid mixtures. Int J Rad Appl Instrum A. 1991;42(11):1095–8.View ArticlePubMedGoogle Scholar


© The Author(s) 2017